摘要
The WHO estimates that almost500 million people world-wide are chronically infected with hepatitis B and C viruses(HBV and HCV)and human immune deficiency virus(HIV).During the recent years,significant progress was made in treatment of chronic infection with HBV,HCV,and HIV,mainly based on directly antiviral agents.However,
The WHO estimates that almost 500 million people world-wide are chronically infected with hepatitis B and C viruses （HBV and HCV） and human immune deficiency virus （HIV）.During the recent years,significant progress was made in treatment of chronic infection with HBV,HCV,and HIV,mainly based on directly antiviral agents.However,major challenges for the medical research remain.The current treatment regimens for HBV and HIV do still not sufficiently achieve complete viral eradication in patients.
基金
supported by theDFG through SFB TRR60
